ERBB2 and cancer: In a panel of cell lines, CAR-EXO-CTX and CAR-EXO-TTZ show notable cytotoxic effects on EGFR-expressing cells or HER2-expressing cells, while cancer cells with low antigen expression seemed to be resistant to exosome-mediated lysis (Supplementary Table 1).